US Stock MarketDetailed Quotes

INCY Incyte

Watchlist
  • 63.560
  • +0.200+0.32%
Close Sep 13 16:00 ET
  • 64.320
  • +0.760+1.20%
Post 17:26 ET
12.24BMarket Cap155.02P/E (TTM)

Incyte Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Incyte Q2 2024 Earnings Date

Currency：USDJul 30, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
1.01B
1.04B
+29.04M
Beat Est.
+6.30%
+9.34%
+2.86%
EPS
0.83
-2.04
-2.87
Miss Est.
-7.34%
-326.67%
-344.63%
Analyst Rating
Buy

Sep 13, 2024

Incyte Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 18 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.139B--
--2024/Q3-- / 1.076B--
Jul 30, 20242024/Q21.044B / 1.015B--
Apr 30, 20242024/Q1880.889M / 924.642M--
Feb 13, 20242023/Q41.013B / 1.003B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.139B--
--2024/Q3-- / 1.076B--
Jul 30, 20242024/Q21.044B / 1.015B--
Apr 30, 20242024/Q1880.889M / 924.642M--
Feb 13, 20242023/Q41.013B / 1.003B--

Unlock Free Earnings Estimates

Incyte Earnings Reports

  • Incyte | 10-Q: Q2 2024 Earnings Report

    Jul 30 16:18 ET

  • Incyte | 10-Q: Q1 2024 Earnings Report

    Apr 30 16:58 ET

  • Incyte | 10-K/A: Annual report (Amendment)

    Feb 16 16:08 ET

  • Incyte | 10-K: FY2023 Annual Report

    Feb 13 22:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 13, 2024

    Buy

    • Buy

      53.85%

    • Hold

      38.46%

    • Sell

      7.69%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept CAR-T Therapy
    CAR-T Therapy
    Intraday+0.37%